As Governors Plead for Tests, Trump Promises Ventilators to Europe
Maryland, Virginia and Arizona issued statewide stay-at-home orders, and the F.D.A. granted emergency approval for the use of two malaria drugs to treat some coronavirus patients.
Hydroxychloroquine has become controversial but it is not a treatment for Covid, say Oxford researchers.
(Natural News) One of the most vocal media opponents to hydroxychloroquine, the generic anti-malaria drug that President Trump touted as having benefits, is NBC News. For the past several weeks at least, NBC News has been churning out story after story claiming that hydroxychloroquine does not help prevent or treat the Wuhan coronavirus (COVID-19). In...
[VOA] The challenges faced by African nations during the coronavirus pandemic are about much more than a rapidly spreading virus, American aid officials say. They're concerned about the threats it poses to proper nutrition, the economy, liberties and freedoms, and the ongoing war against a deadly parasite that has plagued this continent for centuries: malaria.
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report
The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated clinical trial released on Wednesday.
Questions raised over study claiming drug linked to higher rate of mortality and heart problems in Covid-19 patientsSign up for Guardian Australia ’s coronavirus emailDownload the free Guardian app to get the most important news notificationsCoronavirus Australia maps and cases: live numbers and statisticsThe World Health Organization will resume clinical trials of an anti-malaria drug researchers hope may treat Covid-19, after a study of the drug published in May by a major medical journal prompted them to halt trials due to safety concerns.The paper, published in the Lancet, said hydroxychloroquine was associated w...
On June 3, the World Health Organization (WHO) resumed a study looking into whether the malaria drug hydroxychloroquine could be effective in treating COVID-19. Last week, the WHO temporarily stopped people from enrolling in the trial, part of a larger study called Solidarity that is investigating a number of different potential coronavirus therapies, over concerns about the hydroxychloroquine’s adverse effects on the heart. That followed the publication of a Lancet study on May 22, involving more than 96,000 people, which found that the drug did not improve survival among patients hospitalized with COVID-19, and tha...
The White House medical team kept a close eye on President Donald Trump’s heart rhythms, including at least one electrocardiogram, when he took a two-week course of a malaria drug to try to prevent the coronavirus
Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus. The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.
U.S. President Donald Trump had no side effects from a two-week course of hydroxychloroquine, an anti-malaria drug that can cause heart problems, after using it as a preventive measure against the coronavirus, his White House physician said on Wednesday.